Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
GILEAD SCIENCES, INC.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-37.1% vs price
Base Case (Median)
0.5% vs price
Bull Case (75th pct.)
67.3% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $379.37 | 164.2% | High (40%) |
| EV/EBITDA | $94.79 | -34.0% | Medium (20%) |
| EV/FCF | $193.79 | 35.0% | Medium (20%) |
| Earnings Power Value | $76.84 | -46.5% | Medium (50%) |
Based on 4 out of 7 methods, GILD appears fairly valued at the current price of $143.58. The base case fair value of $144.29 implies 0.5% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.